Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Rucaparib - drug evaluation: a PARP inhibitor for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer.
Journal: Future oncology (London, England)
Published: June 18, 2026
Real-World Efficacy and Safety of Belzutifan in Sporadic Metastatic Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: April 22, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 16, 2025
Cardiotoxicity risk in metastatic castration-resistant prostate cancer: enzalutamide versus abiraterone.
Journal: Cardio-oncology (London, England)
Published: October 24, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 25, 2025
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis.
Journal: European urology
Published: May 10, 2025
Systemic treatment options for metastatic castration resistant prostate cancer: A living systematic review.
Journal: medRxiv : the preprint server for health sciences
Published: May 05, 2025
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 02, 2025
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.
Journal: JCO oncology practice
Published: December 19, 2024
Last Updated: 09/26/2026